Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: J Am Coll Surg. 2019 Feb 10;229(1):19–27.e1. doi: 10.1016/j.jamcollsurg.2019.01.016

Figure 2.

Figure 2.

Subgroup analysis on overall survival comparing CTx (chemotherapy) only vs CTx+IT (immunotherapy) in the propensity matched cohort factors with high risk factors: (A) R1 margin status, (B) positive lymph node, and (C) poorly differentiated disease.